Skip to main content
. 2020 Jun 11;10(6):394. doi: 10.3390/diagnostics10060394

Table 2.

Expression of PD-L1 in immune cells and tumour cells.

Types Total Number of Cases (n) PD-L1 Positive in Immune Cells n (%) p Value PD-L1 Positive in Tumour Cells n (%)
Endometrial carcinoma 59 37 (62.7) <0.001 * 17 (28.8)
Non-neoplastic endometrium 32 0 (0) NA

* p value < 0.05 is considered as significant; NA: not applicable.